SecBot SecBot
Insider Buy ·Filed Nov 6, 2026

MDGL

MADRIGAL PHARMACEUTICALS, INC.
BULLISH
Impact 5/10
Horizonweeks Processed10d 8h ago SEC0001193125-26-452132
Insider cluster: 1 insiders, $2.1M total
Actionable Insight ▲ Bullish

The Baker Bros. purchase cluster signals strong insider alignment with the company's post-earnings trajectory. Monitor next quarter's Rezdiffra sales trajectory and the MAESTRO-CSPH trial enrollment for sustained revenue growth.

DirectionBullish
Confidencehigh
Horizonweeks

How the stock moved after the report

⚠ Clustered BULLISH VIEWSTOCK BELOW ENTRY AT T+5
Entry
$432.79
T+0 close · Nov 6, 2026 · via day close
Latest settled
−2.04%
T+5 · $423.96
Vs SPY
−0.35%
α at T+5
Next horizon
T+20
in 21d
  1. T+0 · Nov 9 $432.79entry
  2. T+1 · 7d ago −0.04%α +0.32% · $432.60
  3. T+5 · 20h ago −2.04%α −0.35% · $423.96
  4. T+20 · in 21d Pending
  5. T+60 · in 3mo Pending

Price Chart

Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

Baker Bros. Advisors, a director and top institutional holder, made a $2.05M open-market purchase of MDGL on Nov 4, 2026, following the company's Q3 earnings report (Nov 3) showing 50% YoY revenue growth to $431.3M and first-ever quarterly profitability. The purchase is part of a larger cluster of Baker Bros. buys totaling ~$35M over the past week, reinforcing insider conviction after strong results.

Key Financial Metrics

Direction
buying
Total Value
$2.1M
Insiders
1

Key Facts

  • Baker Bros. Advisors LP (Director) purchased 5,586 shares at $366.99 on Nov 4, 2026, total $2.05M
  • Purchase is open-market (code P), not under a 10b5-1 plan
  • Q3 2026 revenue $431.3M (50% YoY growth), first profitable quarter with net income $55.4M ($1.83 EPS)
  • Baker Bros. is the largest institutional holder at $1.2B (13F Q2 2026)
  • Total Baker Bros. purchases in the cluster (Nov 4-6) exceed $35M
  • Market cap $9.3B; purchase represents ~0.022% of market cap
  • General Counsel sold $431K on Nov 6, a routine and immaterial sale

Financial Impact

$2.05M open-market purchase by top holder post-strong earnings

insider ownershipmarket confidence

Risk Factors

  • Single insider purchase, albeit by largest holder, does not guarantee future performance
  • General Counsel's small sale is routine and not a counter-signal
  • Dependence on Rezdiffra for nearly all revenue creates concentration risk

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Analyst Consensus
92% bullish (26 analysts)

Investment Themes

Documents Analyzed

This report is based on 1 SEC document filed with EDGAR.

DocumentAccession Number
INSIDER-BUY Data (Synthetic)0001193125-26-452132

Track record

18 reports on MDGL

Performance horizon

3 of 5 bullish or bearish reports moved the stock their way by T+5. Best: +10.26% at T+20 after the Jul 30, 2026 report. 3 of 5 went positive at some point.

Filters
  1. Nov 16, 2026today SC 13G/A Neutral 2/10 Entry $424.08 Now $423.96 −0.03% settles Nov 23
  2. Nov 6, 202610d ago SC 13D/A Neutral 3/10 Entry $432.79 to $423.96 Now $423.96 −2.04% ▼ −2.04% −0.35% vs SPY
  3. Nov 6, 202610d ago Insider Buy Bullish 5/10 Viewing Entry $432.79 to $423.96 Now $423.96 −2.04% ▼ −2.04% −0.35% vs SPY
  4. Nov 6, 202610d ago Insider Cluster Bullish 5/10 Entry $432.79 to $423.96 Now $423.96 −2.04% ▼ −2.04% −0.35% vs SPY
  5. Nov 6, 202610d ago 144 Neutral 2/10 Entry $432.79 to $423.96 Now $423.96 −2.04% ▼ −2.04% −0.35% vs SPY
  6. Nov 5, 202611d ago Institutional Cluster Mixed 3/10 Entry $400.10 to $425.21 Now $423.96 +5.96% ▲ +6.28% +2.99% vs SPY
  7. Nov 5, 202611d ago Press Release Bullish 5/10 Entry $400.10 to $425.21 Now $423.96 +5.96% ▲ +6.28% +2.99% vs SPY
  8. Nov 3, 202613d ago 8-K Bullish 7/10 No price data
  9. Nov 3, 202613d ago Press Release Bullish 6/10 Entry $396.32 to $432.60 Now $423.96 +6.97% ▲ +9.15% +9.74% vs SPY
  10. Aug 12, 202613w ago 8-K Neutral 3/10 Entry $536.20 to $540.16 Now $423.96 −20.93% ▲ +0.74% +1.18% vs SPY
Showing 10 of 18

US Market Status

Market Closed · Opens in 7h

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Nov 6, 2026